Atlas Trials

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

Clinical trial NCT00620243 · COMPLETED

Trial details

NCT number
NCT00620243
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2004-06-01
Primary completion
2008-11-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.